<?xml version="1.0" encoding="UTF-8"?><rss xmlns:dc="http://purl.org/dc/elements/1.1/" xmlns:content="http://purl.org/rss/1.0/modules/content/" xmlns:atom="http://www.w3.org/2005/Atom" version="2.0"><channel><title><![CDATA[RSS Feed]]></title><description><![CDATA[RSS Feed]]></description><link>http://direct.ecency.com</link><image><url>http://direct.ecency.com/logo512.png</url><title>RSS Feed</title><link>http://direct.ecency.com</link></image><generator>RSS for Node</generator><lastBuildDate>Tue, 21 Apr 2026 22:21:44 GMT</lastBuildDate><atom:link href="http://direct.ecency.com/created/vivocapital/rss.xml" rel="self" type="application/rss+xml"/><item><title><![CDATA[Meet Vivo Capital Team Members]]></title><link>http://direct.ecency.com/vivocapital/@profxt/meet-vivo-capital-team-members</link><guid isPermaLink="true">http://direct.ecency.com/vivocapital/@profxt/meet-vivo-capital-team-members</guid><category><![CDATA[vivocapital]]></category><dc:creator><![CDATA[profxt]]></dc:creator><pubDate>Fri, 14 Sep 2018 05:55:57 GMT</pubDate><enclosure url="https://images.ecency.com/p/2gsjgna1uruv8X2R8t7XDv5HGXyHWCCu4rKmbB5pmEzjYSj7UVFP36rjn65bRAN3ViSiZjhSC85QX1gJBLsW5oRh4Cy5SJA6Nui8UFe8ZQiynHfUTg?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Albert Cha, M.D., Ph.D. (Managing Partner, Vivo Capital)]]></title><description><![CDATA[Albert Cha, M.D., Ph.D. is a Managing Partner who invests in private and public biopharmaceutical and medical device companies. He currently serves on the boards of Ascendis Pharma A/S (NASDAQ: ASND),]]></description><link>http://direct.ecency.com/vivocapital/@profxt/albert-cha-m-d-ph-d-managing-partner-vivo-capital</link><guid isPermaLink="true">http://direct.ecency.com/vivocapital/@profxt/albert-cha-m-d-ph-d-managing-partner-vivo-capital</guid><category><![CDATA[vivocapital]]></category><dc:creator><![CDATA[profxt]]></dc:creator><pubDate>Fri, 14 Sep 2018 05:49:57 GMT</pubDate><enclosure url="https://images.ecency.com/p/2gsjgna1uruv8X2R8t7XDv5HGXyHWCCu4rKmbB5pmEzjYSfXFBNbWWa3rdPo1zY2N6JbwdtV6kSqV9FWXnUcX5CzKhnEpXntAMvcohezVrReWnXPZp?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[Frank Kung, Ph.D., M.B.A. (Managing Partner, Vivo Capital)]]></title><description><![CDATA[Dr. Kung is a founding member of Vivo Capital, LLC (formerly BioAsia Investments), a healthcare/biotechnology venture capital management firm in Palo Alto, California. Dr. Kung started his career in the]]></description><link>http://direct.ecency.com/vivocapital/@profxt/frank-kung-ph-d-m-b-a-managing-partner-vivo-capital</link><guid isPermaLink="true">http://direct.ecency.com/vivocapital/@profxt/frank-kung-ph-d-m-b-a-managing-partner-vivo-capital</guid><category><![CDATA[vivocapital]]></category><dc:creator><![CDATA[profxt]]></dc:creator><pubDate>Fri, 14 Sep 2018 05:44:21 GMT</pubDate><enclosure url="https://images.ecency.com/p/2gsjgna1uruv8X2R8t7XDv5HGXyHWCCu4rKmbB5pmEzjYSfPV3x9pnNq4x2wT4Ejw8YbZQhvTKHGQmJj9uJ6Zjv3XUtXeZqwJSUqzKTxXpHzBGL2Dc?format=match&amp;mode=fit" length="0" type="false"/></item><item><title><![CDATA[About Vivo Capital]]></title><description><![CDATA[Founded in 1996, Vivo Capital is a healthcare investment firm focused on investing in and building high quality companies in the U.S. and China. With more than $1.7 billion under management, Vivo employs]]></description><link>http://direct.ecency.com/vct/@profxt/about-vivo-capital</link><guid isPermaLink="true">http://direct.ecency.com/vct/@profxt/about-vivo-capital</guid><category><![CDATA[vct]]></category><dc:creator><![CDATA[profxt]]></dc:creator><pubDate>Fri, 14 Sep 2018 05:37:15 GMT</pubDate></item></channel></rss>